Literature DB >> 22233286

Diet and its role in interstitial cystitis/bladder pain syndrome (IC/BPS) and comorbid conditions.

Justin I Friedlander1, Barbara Shorter, Robert M Moldwin.   

Abstract

What's known on the subject? and What does the study add? Nearly 90% of patients with interstitial cystitis/bladder pain syndrome (IC/BPS) report sensitivities to a wide variety of dietary comestibles. Current questionnaire-based literature suggests that citrus fruits, tomatoes, vitamin C, artificial sweeteners, coffee, tea, carbonated and alcoholic beverages, and spicy foods tend to exacerbate symptoms, while calcium glycerophosphate and sodium bicarbonate tend to improve symptoms. At present we recommend employing a controlled method to determine dietary sensitivities, such as an elimination diet, in order to identify sensitivities while at the same time maintain optimal nutritional intake. We review current literature with regard to diet's effect upon IC/BPS and common comorbidities (irritable bowel syndrome, fibromyalgia, chronic fatigue syndrome, neuropathic pain, vulvodynia, and headache) with a focus upon questionnaire-based investigations. We discuss the pathologic mechanisms that may link diet and IC/BPS related-pain, concentrating upon specific comestibles such as acidic foods, foods high in potassium, caffeine, and alcohol. Up to 90% of patients with interstitial cystitis/bladder pain syndrome (IC/BPS) report sensitivities to a wide variety of comestibles.   Pathological mechanisms suggested to be responsible for the relationship between dietary intake and symptom exacerbation include peripheral and/or central neural upregulation, bladder epithelial dysfunction, and organ 'cross-talk', amongst others.   Current questionnaire-based data suggests that citrus fruits, tomatoes, vitamin C, artificial sweeteners, coffee, tea, carbonated and alcoholic beverages, and spicy foods tend to exacerbate symptoms, while calcium glycerophosphate and sodium bicarbonate tend to improve symptoms. Specific comestible sensitivities varied between patients and may have been influenced by comorbid conditions. This suggests that a controlled method to determine dietary sensitivities, such as an elimination diet, may play an important role in patient management.
© 2012 THE AUTHORS. BJU INTERNATIONAL © 2012 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2012        PMID: 22233286     DOI: 10.1111/j.1464-410X.2011.10860.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  22 in total

Review 1.  Female urethral dilation.

Authors:  Tony Bazi; Gael Abou-Ghannam; Raja Khauli
Journal:  Int Urogynecol J       Date:  2013-02-14       Impact factor: 2.894

2.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction.

Authors:  Kari Bo; Helena C Frawley; Bernard T Haylen; Yoram Abramov; Fernando G Almeida; Bary Berghmans; Maria Bortolini; Chantale Dumoulin; Mario Gomes; Doreen McClurg; Jane Meijlink; Elizabeth Shelly; Emanuel Trabuco; Carolina Walker; Amanda Wells
Journal:  Int Urogynecol J       Date:  2016-12-05       Impact factor: 2.894

3.  Treatment effectiveness in interstitial cystitis/bladder pain syndrome: Do patient perceptions align with efficacy-based guidelines?

Authors:  Avril Lusty; Elizabeth Kavaler; Kay Zakariasen; Victoria Tolls; J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

4.  CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome.

Authors:  Ashley Cox; Nicole Golda; Genevieve Nadeau; J Curtis Nickel; Lesley Carr; Jacques Corcos; Joel Teichman
Journal:  Can Urol Assoc J       Date:  2016-05-12       Impact factor: 1.862

Review 5.  Practical use of the new American Urological Association interstitial cystitis guidelines.

Authors:  Renee B Quillin; Deborah R Erickson
Journal:  Curr Urol Rep       Date:  2012-10       Impact factor: 3.092

Review 6.  Painful bladder syndrome: an update and review of current management strategies.

Authors:  Anthony J Dyer; Christian O Twiss
Journal:  Curr Urol Rep       Date:  2014-02       Impact factor: 3.092

Review 7.  Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.

Authors:  Yoshiyuki Akiyama; Yi Luo; Philip M Hanno; Daichi Maeda; Yukio Homma
Journal:  Int J Urol       Date:  2020-04-04       Impact factor: 3.369

8.  [The care situation of patients with interstitial cystitis in Germany: results of a survey of 270 patients].

Authors:  D Jocham; G Froehlich; F Sandig; A Ziegler
Journal:  Urologe A       Date:  2013-05       Impact factor: 0.639

9.  Increased toxic urinary cations in males with interstitial cystitis: a possible cause of bladder symptoms.

Authors:  Sulabha Argade; Zoltan Berecz; Yongxuan Su; C Lowell Parsons
Journal:  World J Urol       Date:  2016-03-30       Impact factor: 4.226

10.  Effects of urine alkalinization with sodium bicarbonate orally on lower urinary tract symptoms in female patients: a pilot study.

Authors:  Mehmet Giray Sönmez; Yunus Emre Göğer; Gökhan Ecer; Ahmet Atıcı; Mehmet Serkan Özkent; Ahmet Öztürk
Journal:  Int Urogynecol J       Date:  2017-10-03       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.